Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer
Jim Weiss: Make It Happen
Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
By Women, for Women: The Untold Stories at the Roots of Oncology
An Appeal for Solidarity, Compassion, and Support for Nepal’s Ongoing Rescue and Recovery Efforts
HUTCHMED Reports Positive Phase 3 SANOVO Results for Savolitinib Plus Osimertinib in EGFR-Mutated NSCLC
The Win-Win Imperative: A Global Call to Make High-Value Cancer Care Affordable
Pashtoon Kasi: Lessons from the NEST Phase 2 Trial in Colon Cancer
The 64th Annual Meeting of the Japan Society of Clinical Oncology (JSCO 2026) will take place on October 22–24, 2026, at the Kobe Convention Center in Kobe, Japan. Held under the theme “One Team to Conquer Cancer,” the meeting will bring together clinicians, researchers, medical staff, and other professionals involved in cancer care for a […]
